Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publicación
Artículo científico (JournalArticle)
Striatal synaptic bioenergetic and autophagic decline in premotor experimental parkinsonism
Synaptic impairment might precede neuronal degeneration in Parkinson’s disease. However, the intimate mechanisms
altering synaptic function by the accumulation of presynaptic α-synuclein in striatal dopaminergic terminals before
dopaminergic death occurs, have not been elucidated. Our aim is to unravel the sequence of synaptic functional and
structural changes preceding symptomatic dopaminergic cell death. As such, we evaluated the temporal sequence
of functional and structural changes at striatal synapses before parkinsonian motor features appear in a rat model of
progressive dopaminergic death induced by overexpression of the human mutated A53T α-synuclein in the substantia
nigra pars compacta, a protein transported to these synapses. Sequential window acquisition of all theoretical mass
spectra proteomics identified deregulated proteins involved first in energy metabolism and later, in vesicle cycling
and autophagy. After protein deregulation and when α-synuclein accumulated at striatal synapses, alterations to mitochondrial bioenergetics were observed using a Seahorse XF96 analyser. Sustained dysfunctional mitochondrial bioenergetics was followed by a decrease in the number of dopaminergic terminals, morphological and ultrastructural
alterations, and an abnormal accumulation of autophagic/endocytic vesicles inside the remaining dopaminergic fibres
was evident by electron microscopy. The total mitochondrial population remained unchanged whereas the number of
ultrastructurally damaged mitochondria increases as the pathological process evolved. We also observed ultrastructural signs of plasticity within glutamatergic synapses before the expression of motor abnormalities, such as a reduction in
axospinous synapses and an increase in perforated postsynaptic densities. Overall, we found that a synaptic energetic
failure and accumulation of dysfunctional organelles occur sequentially at the dopaminergic terminals as the earliest
events preceding structural changes and cell death. We also identify key proteins involved in these earliest functional
abnormalities that may be modulated and serve as therapeutic targets to counterbalance the degeneration of dopaminergic cells to delay or prevent the development of Parkinson’s disease., This study was funded by the Instituto de Salud Carlos III through the projects PI14/00763 and PI19/01915 (co-funded by ERDF/ESF, ‘Investing in your future’). L.M.-G. held a Predoctoral Research Fellowship from the University of the Basque Country (UPV/EHU). T.R.-C. and A.Q.-V. were funded by CIBERNED. T.R.-C. held a Fundación Jesús de Gangoiti Barrera Foundation grant (Bilbao, Spain). H.J.-U. and A.B.-I. held a Predoctoral Research Fellowship from the Government of the Basque Country. Israel Science Foundation (536/19) and the Spanish Ministry of Science (SAF2016-78071-R) funded the contribution of S.K. and A.O.